• Victor J Thannickal, Mahadev Murthy, William E Balch, Navdeep S Chandel, Silke Meiners, Oliver Eickelberg, Moisés Selman, Annie Pardo, Eric S White, Bruce D Levy, Paula J Busse, Rubin M Tuder, Veena B Antony, Jacob I Sznajder, and G R Scott Budinger.
• 1 University of Alabama at Birmingham, Birmingham, Alabama.
• Am. J. Respir. Crit. Care Med. 2015 Feb 1; 191 (3): 261-9.

AbstractThe aging of the population in the United States and throughout the developed world has increased morbidity and mortality attributable to lung disease, while the morbidity and mortality from other prevalent diseases has declined or remained stable. Recognizing the importance of aging in the development of lung disease, the American Thoracic Society (ATS) highlighted this topic as a core theme for the 2014 annual meeting. The relationship between aging and lung disease was discussed in several oral symposiums and poster sessions at the annual ATS meeting. In this article, we used the input gathered at the conference to develop a broad framework and perspective to stimulate basic, clinical, and translational research to understand how the aging process contributes to the onset and/or progression of lung diseases. A consistent theme that emerged from the conference was the need to apply novel, systems-based approaches to integrate a growing body of genomic, epigenomic, transcriptomic, and proteomic data and elucidate the relationship between biologic hallmarks of aging, altered lung function, and increased susceptibility to lung diseases in the older population. The challenge remains to causally link the molecular and cellular changes of aging with age-related changes in lung physiology and disease susceptibility. The purpose of this review is to stimulate further research to identify new strategies to prevent or treat age-related lung disease.

22 keywords...

hide…